Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone-Reference-Cited by-同舟云学术

Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone

Published:2013-04 Issue:7 Volume:12 Page:1042-1057
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Miquet Johanna G.,Freund Thomas,Martinez Carolina S.,González Lorena,Díaz María E.,Micucci Giannina P.,Zotta Elsa,Boparai Ravneet K.,Bartke Andrzej,Turyn Daniel,Sotelo Ana I.

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.24026

Reference80 articles.

1. The growth hormone receptor: mechanism of activation and clinical implications

2. How growth hormone controls growth, obesity and sexual dimorphism

3. Chapter 6 Crosstalk Between Growth Hormone and Insulin Signaling

4. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice.

5. Plasma Growth Hormone Pattern Regulates Epidermal Growth Factor (EGF) Receptor Messenger Ribonucleic Acid Levels and EGF Binding in the Rat Liver*

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WIP1 is a novel specific target for growth hormone action;iScience;2023-11

2. Liver impact of growth hormone (GH) intermittent treatment during the growth period in mice;Molecular and Cellular Endocrinology;2023-05

3. Insulin signaling in the heart is impaired by growth hormone: a direct and early event;Journal of Molecular Endocrinology;2022-08-01

4. Mice with gene alterations in the GH and IGF family;Pituitary;2021-11-19

5. Growth Hormone Modulation of Hepatic Epidermal Growth Factor Receptor Signaling;Trends in Endocrinology & Metabolism;2021-06